LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, announced today that management has begun the preliminary due diligence and strategic planning process for expanding into Colombia. The initiative includes evaluating corporate, regulatory, legal, operational, and commercial requirements to establish a Colombian operating subsidiary and deploy the company's digital healthcare platform in the market.
Management believes Colombia represents an attractive long-term opportunity as part of its broader Latin American expansion strategy. The ongoing review will assess corporate formation, regulatory compliance, healthcare technology implementation, strategic partnerships, local operational infrastructure, and other market entry considerations necessary to support future operations.
The company stated that the evaluation is intended to build upon its growing healthcare ecosystem by identifying opportunities to expand access to telehealth infrastructure, healthcare coordination technologies, digital healthcare services, insurance accessibility initiatives, pharmacy integration opportunities, payment accessibility solutions, and artificial intelligence-driven healthcare technologies in additional Latin American markets.
Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., commented: "Colombia represents an important strategic opportunity as we continue executing our long-term vision of building an integrated digital healthcare ecosystem across Latin America. While we remain in the early stages of evaluating market entry requirements, we believe it is important to establish the proper legal, operational, and strategic foundation before expanding into new jurisdictions."
The company emphasized that the Colombia expansion initiative remains in the preliminary planning and due diligence stage. Management intends to complete the required corporate, regulatory, and operational review before proceeding with the establishment of a Colombian subsidiary and expects to provide additional updates as material developments occur.
LataMed AI is focused on developing technology platforms designed to support healthcare access, patient engagement, provider coordination, emergency medical response, pharmacy integration, insurance accessibility, payment solutions, and data-driven healthcare operations, with an initial regional focus on Latin America.
For additional information, visit the company's website at https://latamed.ai or review its filings with the U.S. Securities and Exchange Commission at www.sec.gov.
